documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
20 rows where docket_id = "FDA-2023-N-0061" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2023-N-0061-0050 | FDA | None FDA-2023-N-0061 | TAB C - 2013-930-Drug Products-PRIA-FINAL | Supporting & Related Material | Background Material | 2024-11-06T05:00:00Z | 2024 | 11 | 2024-11-06T17:02:05Z | 0 | 0 | 0900006486800148 | |||
| FDA-2023-N-0061-0045 | FDA | None FDA-2023-N-0061 | TAB A - 2013-930-Drug Products-Proposed Rule-ORIGINAL | Supporting & Related Material | Background Material | 2024-11-06T05:00:00Z | 2024 | 11 | 2024-11-06T17:01:31Z | 0 | 0 | 0900006486800149 | |||
| FDA-2023-N-0061-0049 | FDA | None FDA-2023-N-0061 | TAB B - 2013-930-Drug Products-PRIA-TRACK CHANGE FROM ORIGINAL TO FINAL | Supporting & Related Material | Background Material | 2024-11-06T05:00:00Z | 2024 | 11 | 2024-11-06T17:01:59Z | 0 | 0 | 0900006486800147 | |||
| FDA-2023-N-0061-0046 | FDA | None FDA-2023-N-0061 | TAB B - 2013-930-Drug Products-Proposed Rule-TRACK CHANGE FROM ORIGINAL TO FINAL | Supporting & Related Material | Background Material | 2024-11-06T05:00:00Z | 2024 | 11 | 2024-11-06T17:01:38Z | 0 | 0 | 090000648680014a | |||
| FDA-2023-N-0061-0048 | FDA | None FDA-2023-N-0061 | TAB A - 2013-930-Drug Products-PRIA-ORIGINAL | Supporting & Related Material | Background Material | 2024-11-06T05:00:00Z | 2024 | 11 | 2024-11-06T17:01:54Z | 0 | 0 | 0900006486800144 | |||
| FDA-2023-N-0061-0047 | FDA | None FDA-2023-N-0061 | TAB C - 2013-930-Drug Products-Proposed Rule-FINAL | Supporting & Related Material | Background Material | 2024-11-06T05:00:00Z | 2024 | 11 | 2024-11-06T17:01:44Z | 0 | 0 | 090000648680014b | |||
| FDA-2023-N-0061-0044 | FDA | None FDA-2023-N-0061 | Memorandum - Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act (Proposed Rule) | Other | Memorandum | 2024-11-06T05:00:00Z | 2024 | 11 | 2024-11-06T05:00:00Z | 2024-11-06T17:00:18Z | 0 | 0 | 09000064867ffe78 | ||
| FDA-2023-N-0061-0004 | FDA | None FDA-2023-N-0061 | Reference 02 PCAC transcript March 9 2016 | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:37:08Z | 0 | 0 | 0900006486487b7d | |||
| FDA-2023-N-0061-0012 | FDA | None FDA-2023-N-0061 | Reference 09 PCAC briefing May 8-9 2017 | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:47:41Z | 0 | 0 | 09000064864886b6 | |||
| FDA-2023-N-0061-0013 | FDA | None FDA-2023-N-0061 | Reference 10a PCAC briefing Nov 20-21 2017 | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:48:46Z | 0 | 0 | 09000064864886a3 | |||
| FDA-2023-N-0061-0007 | FDA | None FDA-2023-N-0061 | Reference 05 PCAC transcript Nov 21 2017 | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:40:06Z | 0 | 0 | 0900006486487b80 | |||
| FDA-2023-N-0061-0001 | FDA | None FDA-2023-N-0061 | Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T04:00:00Z | 2024-06-19T03:59:59Z | 2024-06-20T01:00:32Z | 2024-05801 | 0 | 0 | 090000648648745b |
| FDA-2023-N-0061-0009 | FDA | None FDA-2023-N-0061 | Reference 07a PCAC briefing March 8-9 2016 | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:44:38Z | 0 | 0 | 09000064864886b3 | |||
| FDA-2023-N-0061-0006 | FDA | None FDA-2023-N-0061 | Reference 04 PCAC transcript May 8-9 2017 | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:39:08Z | 0 | 0 | 0900006486487b7f | |||
| FDA-2023-N-0061-0010 | FDA | None FDA-2023-N-0061 | Reference 07b PCAC briefing March 8-9 2016 errata and addendum | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:45:43Z | 0 | 0 | 09000064864886b4 | |||
| FDA-2023-N-0061-0008 | FDA | None FDA-2023-N-0061 | Reference 06 PCAC briefing June 17-18 2015 | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:41:55Z | 0 | 0 | 09000064864886b2 | |||
| FDA-2023-N-0061-0003 | FDA | None FDA-2023-N-0061 | Reference 01 PCAC transcript June 18 2015 | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:36:09Z | 0 | 0 | 0900006486487b7c | |||
| FDA-2023-N-0061-0005 | FDA | None FDA-2023-N-0061 | Reference 03 PCAC transcript Nov 3 2016 | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:38:12Z | 0 | 0 | 0900006486487b7e | |||
| FDA-2023-N-0061-0011 | FDA | None FDA-2023-N-0061 | Reference 08 PCAC briefing Nov 3 2016 | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:46:39Z | 0 | 0 | 09000064864886b5 | |||
| FDA-2023-N-0061-0002 | FDA | None FDA-2023-N-0061 | Reference Summary List for Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under sections 503A and 503B | Supporting & Related Material | Background Material | 2024-03-20T04:00:00Z | 2024 | 3 | 2024-03-20T15:34:54Z | 0 | 0 | 0900006486487b7b |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;